Literature DB >> 26885126

Intracytoplasmic sperm injection (ICSI) outcomes of azoospermia with different causes: 107 cases report.

Xu-Jun Yu1, Liang Dong2, Fei-Qiang Ren2, Di-Ang Chen2, Pei-Hai Zhang3, Jian Cai4, Yao-Dong You4, Guang-Sen Li4, De-Gui Chang5.   

Abstract

This retrospective analysis compared the outcomes of fertilization and pregnancy rates of 107 azoospermia patients treating with intracytoplasmic sperm injection (ICSI). Sperms were obtained by testicular biopsy surgery, with which we used in ICSI subsequently. The outcomes were compared by different kinds of causes leading to azoospermia in the 107 cases. 69 cases of obstructive azoospermia and 38 cases non-obstructive, the fertilization rates were 61.94% and 53.47% respectively, and pregnancy rates were 67.65% and 52.63%. 78 cases with normal volume testes and 29 cases with small testes, the fertilization rates were 70.93% and 48.80% respectively, and pregnancy rates were 66.25% and 50.00%. There was significant difference in fertilization rates between obstructive, non-obstructive and normal volume testes, small testes (P < 0.05), but no significant difference in pregnancy rates (P > 0.05). The pregnancy rate was significant difference between female age < 32 and ≥ 32 whatever the cause of azoospermia was (P < 0.05). Our study reveals that obstructive azoospermia and normal volume testes have higher fertilization rates in ICSI, but the pregnancy rates are only related to female age.

Entities:  

Keywords:  Azoospermia; ICSI outcomes; different causes; male infertility

Year:  2015        PMID: 26885126      PMCID: PMC4723971     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  8 in total

1.  Comparison of conventional in vitro fertilisation and intracytoplasmic sperm injection outcomes in patients with moderate oligoasthenozoospermia.

Authors:  H-L Shuai; Q Ye; Y-H Huang; B-G Xie
Journal:  Andrologia       Date:  2014-05-09       Impact factor: 2.775

2.  Effects of maternal ageing on ICSI outcomes and embryo development in relation to oocytes morphological characteristics of birefringent structures.

Authors:  Cem Korkmaz; Yesim Bayoglu Tekin; Mehmet Sakinci; Cihangir Mutlu Ercan
Journal:  Zygote       Date:  2014-05-29       Impact factor: 1.442

3.  Etiology of azoospermia in a military population.

Authors:  Suzanne R Gudeman; Blair Townsend; Kimberly Fischer; Rustin C Walters; Donald Crain
Journal:  J Urol       Date:  2014-10-16       Impact factor: 7.450

4.  Birth defects after assisted reproductive technologies in China: analysis of 15,405 offspring in seven centers (2004 to 2008).

Authors:  Junhao Yan; Guoning Huang; Yingpu Sun; Xiaoming Zhao; Shiling Chen; Shuhua Zou; Cuifang Hao; Song Quan; Zi-Jiang Chen
Journal:  Fertil Steril       Date:  2010-09-20       Impact factor: 7.329

Review 5.  Clinical management of infertile men with nonobstructive azoospermia.

Authors:  Sandro C Esteves
Journal:  Asian J Androl       Date:  2015 May-Jun       Impact factor: 3.285

6.  ICSI treatment of severe male infertility can achieve prospective embryo quality compared with IVF of fertile donor sperm on sibling oocytes.

Authors:  Ju-Fen Zheng; Xiao-Bao Chen; Lei-Wen Zhao; Min-Zhi Gao; Jie Peng; Xian-Qin Qu; Hui-Juan Shi; Xing-Liang Jin
Journal:  Asian J Androl       Date:  2015 Sep-Oct       Impact factor: 3.285

7.  The azoospermic male: current knowledge and future perspectives.

Authors:  Sandro C Esteves; Ashok Agarwai
Journal:  Clinics (Sao Paulo)       Date:  2013       Impact factor: 2.365

8.  ICSI Outcome in Infertile Couples with Different Causes of Infertility: A Cross-Sectional Study.

Authors:  Mahnaz Ashrafi; Shahideh Jahanian Sadatmahalleh; Mohammad Reza Akhoond; Firouzeh Ghaffari; Zahra Zolfaghari
Journal:  Int J Fertil Steril       Date:  2013-07-31
  8 in total
  1 in total

1.  Effect of oral alpha-lipoic acid (ALA) on the treatment of male infertility: A protocol for systematic review and meta-analysis.

Authors:  Liang Dong; Xiaojin Zhang; Fang Yang; Junjun Li; Xujun Yu; Yulin Li
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.889

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.